Hello,
Welcome to Insider Healthcare. I'm healthcare editor Leah Rosenbaum, and today in healthcare news:
- We have the pitch deck from Belong Health's Series A to help low-income older adults;
- We also have the pitch deck from Akido Lab's Series A to collect public health data;
- An Insider analysis shows that the most common health conditions don't always receive the most funding.
If you're new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @leah_rosenbaum. Let's get to it…

Associated Press/ Nati Harnik
Here is the 29-slide presentation a former Cigna executive used to raise $40 million to improve how lower-income older adults receive healthcare

- Belong Health works with insurance companies to provide care to dually eligible patients.
- On Wednesday, it raised $40 million in Series A funding from NEA and Maverick Ventures.
- CEO Patrick Foley also worked at Medicare startup HealthSpring, which was acquired by Cigna in 2012.

Jamilette Mota, 17, receives her Pfizer COVID-19 vaccine from student registered nurse Josselyn Solano at a mobile clinic for underserved communities in Los Angeles, California on April 20.Al Seib/Los Angeles Times/Getty Images
Here is the 12-slide presentation that convinced health-tech juggernauts like Anne Wojcicki and Elad Gil to back a public health data analytics startup

- Akido Labs makes data analytics software for first responders working with at-risk populations.
- On Thursday, it raised $25 million in Series A funding.
- Its software helped track COVID-19 outbreaks among populations experiencing houselessness.

A digital generated image of a COVID-19 cell.Andriy Onufriyenko/Getty Images
We looked at what conditions receive the most research funding compared with the leading causes of death in the US. Here's what we learned from 2021.

- Heart disease, cancer, COVID-19, unintentional injuries, and strokes claimed the most lives in 2020.
- The conditions that caused the most deaths and the best-funded conditions often don't align.
- COVID-19 is a new entrant to leading causes of death and to research funding areas.
More stories we're reading:
- Vaccines could still protect against Omicron via powerful 'T cells' that are hard to measure but prevent severe illness and death (Insider)
- A reporter talks to an expert about how to stop people from hacking medical devices (Politico)
- Is Omicron as infectious as it gets? Scientists lay out their best and worst scenarios for the virus' future. (Insider)
- New documents show that COVID-19 tests used by the CDC were badly designed and potentially contaminated (The New York Times)
-Leah
Read the original article on Business Insider